FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Human Disease Model Report: intrauterine growth restriction, symmetrical, insulin-signaling-related
Open Close
General Information
Name
intrauterine growth restriction, symmetrical, insulin-signaling-related
FlyBase ID
FBhh0000601
Disease Ontology Term
Parent Disease
OMIM
Overview

Intrauterine growth restriction (IUGR) in humans can be caused by a number of factors, one of which is prenatal abnormalities in insulin-like growth factor signaling. Symmetrical IUGR is associated with global growth restriction, decreased cell proliferation, significant lethality at birth, and learning defects. Mutations in the chico gene in Drosophila, the single fly ortholog of the human insulin receptor substrate genes (IRS1, IRS2, IRS4), result in the same repertoire of phenotypes. Classical amorphic and hypomorphic alleles, RNAi-targeting constructs, and alleles caused by insertional mutagenesis have been generated for Dmel\chico.

None of the human insulin receptor substrate genes has been introduced into flies.

Animals homozygous for an amorphic mutation of chico have lower body weight, fewer ommatidia, smaller wings, and fewer cells per wing than wild type; they exhibit learning defects and females are sterile. It has been shown that chico mutations disrupt olfactory associative learning, at least in part, by reducing cAMP signaling in specific parts of the brain and that this phenotype can be rescued by overexpression of a downstream adenylyl cyclase gene. Thus, it is postulated that cognitive defects associated with IUGR related to reduced insulin signaling may occur from acute reductions in cAMP signaling, independently of developmental defects. Many genetic and physical interactions of Dmel\chico have been described; see below and in the chico gene report.

[updated Sep. 2017 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: intrauterine growth restriction, symmetrical, insulin-signaling-related
OMIM report
Human gene(s) implicated
Symptoms and phenotype

Intrauterine growth restriction (IUGR) has been defined as a rate of fetal growth that is below normal in light of the growth potential of a specific infant as per the race and gender of the fetus (Sharma et al., 2016; pubmed:27441006).

Impaired fetal growth increases the risk of later diabetes and impaired glucose tolerance. Some of this association between birth weight and diabetes may reflect the effect of genetic polymorphisms which reduce insulin action in fetal life as well as after birth (Gatford and Simmons, 2014; pubmed:23820120).

Genetics

Mutations in the chico gene in Drosophila and symmetrical IUGR in humans are associated with several similar phenotypes, including decreased cell proliferation, global growth restriction, significant lethality at birth, and learning defects.

Cellular phenotype and pathology
Molecular information

In flies, chico mutations disrupt olfactory learning, at least in part, by reducing cAMP signaling in specific parts of the brain. Thus, cognitive defects associated with reduced insulin signaling may occur from acute reductions in cAMP signaling, independently of developmental defects.

External links
Disease synonyms
fetal growth restriction
intrauterine growth retardation
IUGR
symmetrical intrauterine growth retardation
symmetrical IUGR
Ortholog Information
Human gene(s) in FlyBase
    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    Many to one: 3 human to 1 Drosophila; the human genes are IRS1, IRS2, IRS4.

    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    Many to one: 3 human to 1 Drosophila; the human genes are IRS1, IRS2, IRS4.

    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    Many to one: 3 human to 1 Drosophila; the human genes are IRS1, IRS2, IRS4.

    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (1)
      Gene Snapshot
      chico (chico) encodes a substrate of the product of InR. As a key component of the Insulin pathway, the chico product plays an essential role in the control of cell size and growth. [Date last reviewed: 2019-06-13]
      Gene Groups / Pathways
      Comments on ortholog(s)

      Moderate-scoring ortholog of human IRS1, IRS2, IRS4 (1 Drosophila to 3 human). Dmel\chico shares 21-23% identity and 34-37% similarity with the human genes.

      Orthologs and Alignments from DRSC
      DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (28 groups)
        protein-protein
        Interacting group
        Assay
        References
        anti tag coimmunoprecipitation, peptide massfingerprinting, Identification by mass spectrometry
        anti tag coimmunoprecipitation, peptide massfingerprinting, Identification by mass spectrometry
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        experimental knowledge based
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry, peptide massfingerprinting, two hybrid, fluorescent resonance energy transfer
        experimental knowledge based
        fluorescent resonance energy transfer, anti tag coimmunoprecipitation, western blot
        experimental knowledge based, anti tag coimmunoprecipitation, peptide massfingerprinting
        anti tag coimmunoprecipitation, peptide massfingerprinting
        anti tag coimmunoprecipitation, peptide massfingerprinting, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry, peptide massfingerprinting
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        experimental knowledge based
        experimental knowledge based
        Alleles Reported to Model Human Disease (Disease Ontology) (8 alleles)
        Models Based on Experimental Evidence ( 4 )
        Modifiers Based on Experimental Evidence ( 5 )
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        amorphic allele - molecular evidence
        P-element activity
        amorphic allele - molecular evidence
        P-element activity
        References (4)